Atlas Trials

Study to Find Out How Long it Takes Azelastine Hydrochloride 0.15% Nasal Spray to Relieve Symptoms in Patients Suffering From Allergic Rhinitis

Clinical trial NCT04264637 · COMPLETED

Trial details

NCT number
NCT04264637
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Allergic Rhinitis
Start date
2020-02-03
Primary completion
2021-03-17
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.